Darling Ingredients (DAR) EVP Colpaert gets 9,252 shares, 4,580 withheld for taxes
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
Darling Ingredients EVP Jeroen Colpaert reported equity compensation activity involving company common stock. He received 9,252 shares as a grant or award, at no cash cost, upon vesting of performance shares tied to the 2023–2025 performance period. To cover tax obligations, 4,580 shares were disposed of at $51.92 per share through share withholding rather than an open-market sale. After these transactions, Colpaert directly holds 29,764 common shares of Darling Ingredients.
Positive
- None.
Negative
- None.
Insider Trade Summary
2 transactions reported
Mixed
2 txns
Insider
Colpaert Jeroen
Role
EVP Rousselot
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Common Stock | 9,252 | $0.00 | -- |
| Tax Withholding | Common Stock | 4,580 | $51.92 | $238K |
Holdings After Transaction:
Common Stock — 34,344 shares (Direct)
Footnotes (1)
- [object Object]
FAQ
What did Darling Ingredients (DAR) EVP Jeroen Colpaert report in this Form 4?
EVP Jeroen Colpaert reported routine equity compensation activity. He received 9,252 Darling Ingredients common shares from vested performance awards and had 4,580 shares withheld to satisfy tax obligations, leaving him with 29,764 directly held shares after the transactions.
What is the nature of the equity award reported by Darling Ingredients (DAR) EVP Colpaert?
The award consists of common shares received upon vesting of performance shares for the 2023–2025 period. According to the disclosure, 9,252 shares were issued to Colpaert as compensation, aligning with performance-based incentives rather than an open-market stock purchase.
Did Jeroen Colpaert execute any open-market trades in Darling Ingredients (DAR) stock?
The reported disposition is a tax-withholding transaction, not an open-market trade. Shares were withheld at $51.92 per share to satisfy tax liabilities on vested performance awards, which is a common administrative mechanism in equity compensation programs instead of a discretionary market sale.